Dianthus Therapeutics CFO Savitz Ryan Buys 74367 Shares for $8.44 on 2026-03-31.

Dianthus Therapeutics, Inc. has disclosed that its Executive Vice President, Chief Financial Officer, and Chief Business Officer, Savitz Ryan, has made several transactions on March 31, 2026. Specifically, Ryan acquired 74,367 shares at $8.44 per share and 40,000 shares at $17.88 per share, while selling 1,390 shares at $78.33 per share, 21,825 shares at $78.86 per share, 1,485 shares at $80.25 per share, 800 shares at $81.36 per share, 2,366 shares at $82.84 per share, 59,800 shares at $83.90 per share, 19,469 shares at $84.57 per share, and 7,232 shares at $85.54 per share. In addition, Director Paula Soteropoulos sold 599 shares at $80.11 per share and acquired 599 shares at $8.44 per share.